← Back to Discover
Logos Global Management LP
Period ended Jun 30, 2026 · Latest filing Aug 14, 2026
These quarterly holdings are delayed and may not include all assets or short positions.
Values are from the reporting date, not current prices or purchase costs.
The same security may appear in multiple rows.
Source: SEC
Reported portfolio value
Quarter-end reported holdings; not current value or investment performance.
View reported values
- Jun 30, 2026: $2,322,922,487
More quarters will appear as history becomes available.
Top holdings
Top 10 at Jun 30, 2026. Matching entries are combined; security classes and options remain separate. Shares exclude principal amounts; option shares reflect the reported underlying amount.
View top holdings values
- ERASCA INC · COM · 29479A108 · shares: $222,588,000
- ABIVAX SA · SPONSORED ADS · 00370M103 · shares: $136,458,240
- REVOLUTION MEDICINES INC · COM · 76155X100 · shares: $131,096,000
- IDEAYA BIOSCIENCES INC · COM · 45166A102 · shares: $111,810,000
- BIONTECH SE · SPONSORED ADS · 09075V102 · shares: $94,445,750
- VERA THERAPEUTICS INC · CL A · 92337R101 · shares: $94,402,000
- TANGO THERAPEUTICS INC · COM · 87583X109 · shares: $89,091,000
- PRAXIS PRECISION MEDICINES I · COM NEW · 74006W207 · shares: $87,045,400
- CELLDEX THERAPEUTICS INC NEW · COM NEW · 15117B202 · shares: $78,141,000
- DIANTHUS THERAPEUTICS INC · COM · 252828108 · shares: $77,984,000
Reported holdings
68 reported entries| Issuer | Class | CUSIP | Type | Shares / principal | Reported value (USD) |
|---|---|---|---|---|---|
| ERASCA INC | COM | 29479A108 | — | 12,150,000 shares | $222,588,000 |
| ABIVAX SA | SPONSORED ADS | 00370M103 | — | 1,024,000 shares | $136,458,240 |
| REVOLUTION MEDICINES INC | COM | 76155X100 | — | 700,000 shares | $131,096,000 |
| IDEAYA BIOSCIENCES INC | COM | 45166A102 | — | 3,000,000 shares | $111,810,000 |
| BIONTECH SE | SPONSORED ADS | 09075V102 | — | 1,015,000 shares | $94,445,750 |
| VERA THERAPEUTICS INC | CL A | 92337R101 | — | 2,200,000 shares | $94,402,000 |
| TANGO THERAPEUTICS INC | COM | 87583X109 | — | 2,850,000 shares | $89,091,000 |
| PRAXIS PRECISION MEDICINES I | COM NEW | 74006W207 | — | 260,000 shares | $87,045,400 |
| CELLDEX THERAPEUTICS INC NEW | COM NEW | 15117B202 | — | 2,100,000 shares | $78,141,000 |
| DIANTHUS THERAPEUTICS INC | COM | 252828108 | — | 800,000 shares | $77,984,000 |
| CG ONCOLOGY INC | COM | 156944100 | — | 1,000,000 shares | $71,050,000 |
| DISC MEDICINE INC | COM | 254604101 | — | 875,000 shares | $63,997,500 |
| MAZE THERAPEUTICS INC | COM | 578784100 | — | 1,935,000 shares | $57,740,400 |
| DYNE THERAPEUTICS INC | COM | 26818M108 | — | 2,550,000 shares | $56,635,500 |
| MOONLAKE IMMUNOTHERAPEUTICS | CLASS A ORD | 61559X104 | — | 2,675,000 shares | $52,082,250 |
| OCULAR THERAPEUTIX INC | COM | 67576A100 | — | 5,300,000 shares | $52,046,000 |
| DESIGN THERAPEUTICS INC | COM | 25056L103 | — | 3,000,000 shares | $43,410,000 |
| OLEMA PHARMACEUTICALS INC | COM | 68062P106 | — | 3,208,875 shares | $40,143,026 |
| BELITE BIO INC | SPONSORED ADS | 07782B104 | — | 250,000 shares | $38,496,250 |
| ACHIEVE LIFE SCIENCE INC | COM | 004468500 | — | 5,425,000 shares | $35,425,250 |
| TREVI THERAPEUTICS INC | COM | 89532M101 | — | 1,880,000 shares | $35,062,000 |
| COGENT BIOSCIENCES INC | COM | 19240Q201 | — | 900,000 shares | $34,830,000 |
| ARRIVENT BIOPHARMA INC | COM | 04272N102 | — | 1,000,000 shares | $34,740,000 |
| CRESCENT BIOPHARMA INC. | COM | G2545C104 | — | 1,900,000 shares | $34,200,000 |
| COMPASS PATHWAYS PLC | SPONSORED ADS | 20451W101 | — | 2,250,000 shares | $31,837,500 |
| MINERALYS THERAPEUTICS INC | COM | 603170101 | — | 1,050,000 shares | $28,329,000 |
| REPLIMUNE GROUP INC | COM | 76029N106 | — | 2,500,000 shares | $27,675,000 |
| XENON PHARMACEUTICALS INC | COM | 98420N105 | — | 450,000 shares | $27,162,000 |
| STRUCTURE THERAPEUTICS INC | SPONSORED ADS | 86366E106 | — | 500,000 shares | $26,835,000 |
| IMMUNOVANT INC | COM | 45258J102 | — | 665,000 shares | $25,622,450 |
| JADE BIOSCIENCES INC | COM NEW | 008064206 | — | 1,125,000 shares | $24,997,500 |
| ENLIVEN THERAPEUTICS INC | COM | 29337E102 | — | 465,000 shares | $23,598,750 |
| VERADERMICS INC | COMMON STOCK | 922967104 | — | 180,000 shares | $22,129,200 |
| AVALO THERAPEUTICS INC | COM NEW | 05338F306 | — | 1,150,000 shares | $21,252,000 |
| ARCUS BIOSCIENCES INC | COM | 03969F109 | — | 650,000 shares | $20,039,500 |
| SUMMIT THERAPEUTICS INC | COM | 86627T108 | — | 1,350,000 shares | $19,669,500 |
| IMMUNOCORE HLDGS PLC | ADS | 45258D105 | — | 600,000 shares | $19,050,000 |
| LB PHARMACEUTICALS INC | COM SHS | 50180M108 | — | 585,000 shares | $18,986,175 |
| MINERVA NEUROSCIENCES INC | COM NEW | 603380205 | — | 3,288,777 shares | $18,252,712 |
| FAETH THERAPEUTICS INC | COM NEW | 81728A207 | — | 722,020 shares | $18,050,500 |
| CRISPR THERAPEUTICS AG | NAMEN AKT | H17182108 | — | 300,000 shares | $16,362,000 |
| DBV TECHNOLOGIES S A | SPONSORED ADS | 23306J309 | — | 915,000 shares | $15,006,000 |
| PARABILIS MEDICINES INC | COM | 698955101 | — | 525,000 shares | $14,369,250 |
| RHYTHM PHARMACEUTICALS INC | COM | 76243J105 | — | 125,000 shares | $13,878,750 |
| VOR BIOPHARMA INC | COM NEW | 929033207 | — | 650,000 shares | $11,966,500 |
| SCHOLAR ROCK HLDG CORP | COM | 80706P103 | — | 200,000 shares | $11,000,000 |
| IMMIX BIOPHARMA INC | COM | 45258H106 | — | 1,000,000 shares | $10,310,000 |
| Q32 BIO INC | COM | 746964105 | — | 800,000 shares | $10,192,000 |
| ODYSSEY THERAPEUTICS INC | COMMON STOCK | 67613T104 | — | 521,736 shares | $9,761,681 |
| ANNEXON INC | COM | 03589W102 | — | 1,500,000 shares | $8,565,000 |
| EDITAS MEDICINE INC | COM | 28106W103 | — | 2,222,000 shares | $7,199,280 |
| RELAY THERAPEUTICS INC | COM | 75943R102 | — | 350,000 shares | $6,548,500 |
| ACADIA PHARMACEUTICALS INC | COM | 004225108 | — | 250,000 shares | $6,325,000 |
| AMYLYX PHARMACEUTICALS INC | COM | 03237H101 | — | 350,000 shares | $6,286,000 |
| CYBIN INC | COM NEW | 23256X407 | — | 750,000 shares | $4,957,500 |
| ONKURE THERAPEUTICS INC | COM CL A | 68277Q105 | — | 963,855 shares | $4,395,179 |
| TENAX THERAPEUTICS INC | COM NEW | 88032L605 | — | 300,000 shares | $4,365,000 |
| DEFINIUM THERAPEUTICS INC | COM SHS | 24477V105 | — | 80,000 shares | $3,763,200 |
| UNICYCIVE THERAPEUTICS INC | COM NEW | 90466Y202 | — | 473,563 shares | $2,221,010 |
| PALATIN TECHNOLOGIES INC | COM NEW | 696077601 | — | 130,000 shares | $1,402,700 |
| UNIQURE NV | SHS | N90064101 | — | 30,000 shares | $1,381,800 |
| JATT II ACQUISITION CORP | ORD SHS | G50765109 | — | 100,000 shares | $1,136,000 |
| RESEARCH ALLIANCE CORP III | ORD SHS CL A | G75226103 | — | 100,000 shares | $1,070,000 |
| ACLARIS THERAPEUTICS INC | COM | 00461U105 | — | 200,000 shares | $1,058,000 |
| LONGEVERON INC | CL A NEW | 54303L203 | — | 1,287,000 shares | $904,761 |
| FRACTYL HEALTH INC | COM | 35168W103 | — | 1,000,000 shares | $794,400 |
| SEPTERNA INC | COM | 81734D104 | — | 23,548 shares | $788,623 |
| AMANAT ACQUISITION CORP | CL A ORD | G0375M101 | — | 50,000 shares | $508,000 |